NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 1063000000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2021-03-31)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2021-03-31
Retrieved: 2026-08-24T01:50:15.362227+02:00
Raw response sha256: d5c307b4378aef96bbf8481f138dd8a0…
Cite as: FACTANKER, https://factanker.com/fact/3b08f76a-5ebd-4f14-8a95-a07d8c8a9054

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies